JP2012528794A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528794A5 JP2012528794A5 JP2012513332A JP2012513332A JP2012528794A5 JP 2012528794 A5 JP2012528794 A5 JP 2012528794A5 JP 2012513332 A JP2012513332 A JP 2012513332A JP 2012513332 A JP2012513332 A JP 2012513332A JP 2012528794 A5 JP2012528794 A5 JP 2012528794A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- subject
- composition
- dengue virus
- dengue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 23
- 229960005486 vaccine Drugs 0.000 claims 18
- 241000725619 Dengue virus Species 0.000 claims 10
- 239000003446 ligand Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 238000002347 injection Methods 0.000 claims 5
- 239000007924 injection Substances 0.000 claims 5
- 208000001490 Dengue Diseases 0.000 claims 4
- 206010012310 Dengue fever Diseases 0.000 claims 4
- 208000025729 dengue disease Diseases 0.000 claims 4
- 230000002163 immunogen Effects 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000000147 enterotoxin Substances 0.000 claims 2
- 231100000655 enterotoxin Toxicity 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 229940046168 CpG oligodeoxynucleotide Drugs 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 108091036414 Polyinosinic:polycytidylic acid Proteins 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims 1
- 229960002751 imiquimod Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18302009P | 2009-06-01 | 2009-06-01 | |
| US61/183,020 | 2009-06-01 | ||
| PCT/US2010/036726 WO2010141386A1 (en) | 2009-06-01 | 2010-05-28 | Compositions and methods for administration of vaccines against dengue virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015230723A Division JP2016033151A (ja) | 2009-06-01 | 2015-11-26 | デングウイルスに対する免疫原性組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528794A JP2012528794A (ja) | 2012-11-15 |
| JP2012528794A5 true JP2012528794A5 (enExample) | 2013-07-18 |
| JP5848243B2 JP5848243B2 (ja) | 2016-01-27 |
Family
ID=43220488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513332A Expired - Fee Related JP5848243B2 (ja) | 2009-06-01 | 2010-05-28 | デングウイルスに対する免疫原性組成物 |
| JP2015230723A Pending JP2016033151A (ja) | 2009-06-01 | 2015-11-26 | デングウイルスに対する免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015230723A Pending JP2016033151A (ja) | 2009-06-01 | 2015-11-26 | デングウイルスに対する免疫原性組成物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9211323B2 (enExample) |
| EP (1) | EP2438198A4 (enExample) |
| JP (2) | JP5848243B2 (enExample) |
| KR (1) | KR101876304B1 (enExample) |
| CN (2) | CN107913406A (enExample) |
| AU (3) | AU2010256845B2 (enExample) |
| CA (1) | CA2763944A1 (enExample) |
| CL (1) | CL2011003043A1 (enExample) |
| CO (1) | CO6470882A2 (enExample) |
| CU (1) | CU20110219A7 (enExample) |
| IL (2) | IL216706A0 (enExample) |
| MX (1) | MX343172B (enExample) |
| MY (1) | MY184428A (enExample) |
| NZ (2) | NZ618158A (enExample) |
| PH (1) | PH12016502431A1 (enExample) |
| SG (1) | SG176299A1 (enExample) |
| WO (1) | WO2010141386A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010256845B2 (en) | 2009-06-01 | 2016-09-22 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| EP2858668A1 (en) * | 2012-06-10 | 2015-04-15 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| US9878031B2 (en) * | 2012-12-14 | 2018-01-30 | Takeda Vaccines, Inc. | Compositions, methods of administration and uses for trivalent dengue virus formulations |
| CA3166063A1 (en) | 2013-03-15 | 2014-09-25 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
| MY192806A (en) | 2016-04-13 | 2022-09-09 | Takeda Vaccines Inc | Compositions and methods of vaccination against dengue virus in children and young adults |
| EP3730620A4 (en) | 2017-12-21 | 2022-01-05 | Green Biomed, Inc. | CROSS-IMMUNIZING ANTIGEN VACCINE AND METHOD OF ITS MANUFACTURING |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| IL298307A (en) | 2018-09-05 | 2023-01-01 | Takeda Vaccines Inc | Dengue fever vaccine unit dose and its administration |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| GB202011055D0 (en) * | 2020-07-17 | 2020-09-02 | Ipsen Bioinnovation Ltd | Treatment of post-operative pain |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233770D1 (de) * | 1991-09-19 | 2009-10-29 | Us Health | Chimäre und/oder wachstumgehemmte Flaviviren |
| FR2741077B1 (fr) * | 1995-11-14 | 1998-01-23 | Pasteur Institut | Vaccin polyvalent anti-dengue |
| JP2002540168A (ja) * | 1999-03-26 | 2002-11-26 | ウォルター リード アーミー インスティテュート オブ リサーチ | 多価デングウイルスワクチン |
| US7094411B2 (en) | 2000-02-16 | 2006-08-22 | The United States Of America As Represented By The Department Of Health And Human Services | Avirulent, immunogenic flavivirus chimeras |
| EP1159969A1 (fr) * | 2000-05-30 | 2001-12-05 | Aventis Pasteur | Vaccine composition |
| EP2290108B1 (en) | 2001-05-22 | 2014-07-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses |
| GB0123580D0 (en) * | 2001-10-01 | 2001-11-21 | Glaxosmithkline Biolog Sa | Vaccine |
| US20040120964A1 (en) | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
| WO2003101397A2 (en) * | 2002-05-31 | 2003-12-11 | Acambis, Inc. | Tetravalent dengue vaccines |
| JP4993301B2 (ja) * | 2004-10-20 | 2012-08-08 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | 日本脳炎ウイルスおよび西ナイルウイルスに対するワクチン |
| US8110196B2 (en) | 2005-04-29 | 2012-02-07 | Polytopas LLC | Methods and compositions for polytopic vaccination |
| US7618393B2 (en) * | 2005-05-03 | 2009-11-17 | Pharmajet, Inc. | Needle-less injector and method of fluid delivery |
| BRPI0613287A2 (pt) * | 2005-06-17 | 2010-12-28 | Sanofi Pasteur | cepa do vìrus da dengue-2 vivo atenuada, composição imunogênica, composição de vacina, ácido nucléico isolado, poliproteìna isolada codificadas pela seq id n .1 ou fragmentos desta e fragmento da poliproteìna |
| WO2007021672A2 (en) * | 2005-08-10 | 2007-02-22 | Acambis Inc. | Vaccination against dengue virus infection |
| CN101287490B (zh) * | 2005-08-10 | 2013-04-24 | 阿坎姆比斯公司 | 对抗登革热病毒感染的疫苗接种 |
| EP2589602B1 (en) * | 2006-08-15 | 2016-04-06 | The Government of the U.S.A., as repr. by the Secretary, Dept. of Health & Human Services, the Nat. Inst. of Health | Development of dengue virus vaccine components |
| FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) * | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| WO2008085288A1 (en) * | 2007-01-11 | 2008-07-17 | Sealed Air Corporation (Us) | Method of shaping insulation |
| US20100316670A1 (en) | 2007-06-14 | 2010-12-16 | Blaney Joseph E | Chimeric sle/dengue type 4 antigenic viruses |
| AU2010256845B2 (en) * | 2009-06-01 | 2016-09-22 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
-
2010
- 2010-05-28 AU AU2010256845A patent/AU2010256845B2/en not_active Ceased
- 2010-05-28 CN CN201711026301.1A patent/CN107913406A/zh active Pending
- 2010-05-28 MX MX2011012807A patent/MX343172B/es active IP Right Grant
- 2010-05-28 CA CA2763944A patent/CA2763944A1/en not_active Abandoned
- 2010-05-28 NZ NZ618158A patent/NZ618158A/en not_active IP Right Cessation
- 2010-05-28 SG SG2011088788A patent/SG176299A1/en unknown
- 2010-05-28 WO PCT/US2010/036726 patent/WO2010141386A1/en not_active Ceased
- 2010-05-28 KR KR1020117031022A patent/KR101876304B1/ko not_active Expired - Fee Related
- 2010-05-28 NZ NZ597000A patent/NZ597000A/en not_active IP Right Cessation
- 2010-05-28 EP EP10783881.5A patent/EP2438198A4/en not_active Withdrawn
- 2010-05-28 MY MYPI2011005768A patent/MY184428A/en unknown
- 2010-05-28 US US12/790,511 patent/US9211323B2/en not_active Expired - Fee Related
- 2010-05-28 CN CN2010800241489A patent/CN102449172A/zh active Pending
- 2010-05-28 JP JP2012513332A patent/JP5848243B2/ja not_active Expired - Fee Related
-
2011
- 2011-11-29 CU CU20110219A patent/CU20110219A7/es unknown
- 2011-11-30 IL IL216706A patent/IL216706A0/en not_active IP Right Cessation
- 2011-12-01 CL CL2011003043A patent/CL2011003043A1/es unknown
- 2011-12-12 CO CO11170641A patent/CO6470882A2/es not_active Application Discontinuation
-
2015
- 2015-11-06 US US14/935,281 patent/US10010600B2/en not_active Expired - Fee Related
- 2015-11-26 JP JP2015230723A patent/JP2016033151A/ja active Pending
- 2015-12-17 IL IL243204A patent/IL243204A0/en unknown
-
2016
- 2016-12-05 PH PH12016502431A patent/PH12016502431A1/en unknown
- 2016-12-22 AU AU2016277660A patent/AU2016277660A1/en not_active Abandoned
-
2019
- 2019-01-11 AU AU2019200212A patent/AU2019200212A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012528794A5 (enExample) | ||
| JP2015520196A5 (enExample) | ||
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| JP2013536240A5 (enExample) | ||
| MY169275A (en) | Method of immunization against the four serotypes of dengue | |
| JP2014528901A5 (enExample) | ||
| HRP20200072T1 (hr) | Načini doziranja za spojeve klase ehinokandina | |
| BR112012010443A2 (pt) | formulação de fármacos e vacinas na forma de agulhas injetáveis por via percutãnea | |
| JP2009514840A5 (enExample) | ||
| JP2016531853A5 (enExample) | ||
| Akbar et al. | A phase III clinical trial with a therapeutic vaccine containing both HBsAg and HBcAg administered via both mucosal and parenteral routes in patients with chronic hepatitis B: 923 | |
| JP2009518410A5 (enExample) | ||
| JP2017502058A5 (enExample) | ||
| JP2017537106A5 (enExample) | ||
| RU2017126153A (ru) | Фармацевтическая комбинация | |
| Chaudhary et al. | Oral premedication with pregabalin and clonidine for hemodynamic stability during laryngoscopy: A comparative study. | |
| WO2005084387A3 (en) | Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer | |
| RU2524430C1 (ru) | Вакцина для профилактики сибирской язвы и некробактериоза животных и способ получения ее | |
| ES2898798T3 (es) | Composiciones de múltiples dosis que contienen un conservante antimicrobiano de poliamida u octenidina | |
| CN105030765A (zh) | 一种镇痛药物组合物及其应用 | |
| KR102494067B1 (ko) | 홍역 백신을 포함하는 용해성 미세바늘 패치 | |
| BR112017012546B1 (pt) | Composição de vacina antirrábica, kit farmacêutico e uso da composição de vacina antirrábica | |
| Savoy | What’s New in Vaccine Science | |
| JP2019512518A5 (enExample) | ||
| RU2021134450A (ru) | Состав на основе мрнк |